Greener thinking

BP forms new partnership to reduce methane emissions

BP has partnered with an environmental nonprofit to reduce emissions of methane. Getty Images

When it comes to greenhouse gas emissions in oil and gas, methane is a less talked about, sneakier culprit compared to carbon dioxide. While it remains in the atmosphere for a shorter period than CO2, methane is 84 times more potent than CO2 during its first 20 years after being emitted into the air.

BP, which has its North American headquarters in Houston, has set out a strategy to minimize its contributions of methane to the atmosphere. The company made a three-year deal with New York-based Environmental Defense Fund to reduce methane emissions in its global supply chain by incorporating new technologies and practices, which will be identified by the new partnership.

"BP is taking a leading role in addressing methane emissions, and this collaboration with EDF is another important step forward for us and for our industry," says Bernard Looney, BP's upstream chief executive, in a release. "We've made great progress driving down emissions across our own business, including meeting our industry-leading methane intensity target of 0.2 percent, but there is much more work to do and partnering with the committed and capable team at EDF will help us develop and share best practices."

BP and EDF will work with universities and third-party experts in order to identify cutting-edge technology for the new initiative, and the company hopes to serve as a leader in reducing greenhouse gas emissions, which is no small undertaking, says Fred Krupp, EDF president, in the release.

"The scale of the methane challenge is enormous, but so is the opportunity," Krupp says. "Whether natural gas can play a constructive role in the energy transition depends on aggressive measures to reduce emissions that include methane. BP took such a step today."

EDF, a nonprofit, won't be paid by BP — per EDF's policy —but BP will assist with funding when it comes to employing experts tasked with finding better technologies to minimize emissions.

"EDF and BP don't agree on everything, but we're finding common ground on methane," Krupp says in the release. "BP has shown early ambition to lead on methane technology. We hope to see more as BP delivers on its own stringent methane goal and we work together to spread solutions industrywide."

BP and EDF have identified three key areas the initiative will focus on this year.

New detection technology
BP will grant up to $500,000 to a detection and quantification technology project at Colorado State University. The initiative includes drone technology and stationary monitoring that hopes to speed up methane emission detection time.

"CSU welcomes this support from BP and EDF for this critical research work, and this provides the necessary confidence and momentum for other stakeholders to contribute in a collaborative environment, in which the results and tools will benefit the wider industry," says Dan Zimmerle, senior research associate for Colorado State University's Energy Institute, in the release.

Advances in digital technology
This year, BP and EDF will announce a digitization project for reducing methane emissions. An EDF report, Fueling the Digital Methane Future, which produced with Accenture Strategy, identified solutions such as machine learning, artificial intelligence, and augmented reality as potential pathways to fewer emissions.

Joint ventures
A 2018 EDF report proved that oil and gas companies can team up to reduce emissions together. BP and EDF plan to host a workshop to find best practices for emission reductions on a larger scale.

Trending News

Building Houston

 
 

From biomolecular research to oral cancer immunotherapy, here are three research projects to watch out for in Houston. Photo via Getty Images

Research, perhaps now more than ever, is crucial to expanding and growing innovation in Houston — and it's happening across the city right under our noses.

In InnovationMap's latest roundup of research news, a couple local scientists are honored by awards while another duo of specialists tackle a new project.

University of Houston professor recognized with award

Mehmet Orman of UH has been selected to receive an award for his research on persister cells. Photo via UH.edu

Mehmet Orman, assistant professor of chemical and biomolecular engineering at the University of Houston Cullen College of Engineering has been honored with a Faculty Early Career Development Award from the National Science Foundation. The award comes with a $500,000 grant to study persister cells — cells that go dormant and then become tolerant to extraordinary levels of antibiotics.

"Nearly all bacterial cultures contain a small population of persister cells," says Orman in a news release. "Persisters are thought to be responsible for recurring chronic infections such as those of the urinary tract and for creating drug-resistant mutants."

Previously, Orman developed the first methods to directly measure the metabolism of persister cells. He also developed cell sorting strategies to segregate persisters from highly heterogeneous bacterial cell populations, and, according to the release, he will be using his methods in the NSF research project.

Houston researchers collaborate on oral cancer innovation

Dr. Simon Young of UTHealth and Jeffrey Hartgerink of Rice University are working on a new use for an innovative gel they developed. Photo via Rice.edu

Two Houston researchers — chemist and bioengineer Jeffrey Hartgerink at Rice University and Dr. Simon Young at the University of Texas Health Science Center at Houston — have again teamed up to advance their previous development of a sophisticated hydrogel called STINGel. This time, they are using it to destroy oral cancer tumors.

SynerGel combines a pair of antitumor agents into a gel that can be injected directly into tumors. Once there, the gel controls the release of its cargo to not only trigger cells' immune response but also to remove other suppressive immune cells from the tumor's microenvironment. The duo reported on the technology in the American Chemical Society journal ACS Biomaterials Science & Engineering.

SynerGel, combines a pair of antitumor agents into a gel that can be injected directly into tumors, where they not only control the release of the drugs but also remove suppressive immune cells from the tumor's microenvironment.

"We are really excited about this new material," Hartgerink says in a news release. "SynerGel is formulated from a specially synthesized peptide which itself acts as an enzyme inhibitor, but it also assembles into a nanofibrous gel that can entrap and release other drugs in a controlled fashion.

In 2018, the pair published research on the use of a multidomain peptide gel — the original STINGel — to deliver ADU-S100, an immunotherapy drug from a class of "stimulator of interferon gene (STING) agonists."

The research is supported by the Oral and Maxillofacial Surgery Foundation, the National Institutes of Health, the Welch Foundation, the National Science Foundation and the Mexican National Council for Science and Technology.

Texas Heart Institute researcher honored by national organization

Dr. James Martin of Texas Heart Institute has been named a senior member of the National Academy of Inventors. Photo courtesy of THI

The National Academy of Inventors have named Houston-based Texas Heart Institute's Dr. James Martin, director of the Cardiomyocyte Renewal Lab, a senior member.

Martin is an internationally recognized developmental and regenerative biologist and his research is focused on understanding how signaling pathways are related to development and tissue regeneration.

"Dr. Martin has long been a steward of scientific advancement and has proven to be a tremendous asset to the Texas Heart Institute and to its Cardiomyocyte Renewal Lab through his efforts to translate fundamental biological discoveries in cardiac development and disease into novel treatment strategies for cardiac regeneration," says Dr. Darren Woodside, vice president for research at THI, in a news release. "Everyone at the Texas Heart Institute is thrilled for Dr. Martin, whose induction into the NAI as a Senior Member is well-deserved."

Martin has authored over 170 peer-reviewed papers in top journals he holds nine U.S. patents and applications, including one provisional application, all of which have been licensed to Yap Therapeutics, a company he co-founded.

The full list of incoming NAI Senior Members, which includes three professionals from the University of Houston, is available on the NAI website.

Trending News